CLINICAL SPECTRUM TIME COURSE IN NON ANTI JO-1 POSITIVE ANTISYNTHETASE SYNDROME

被引:1
|
作者
Cavagna, L. [1 ,2 ]
Andersson, H. [3 ]
Gonazlez-Gay, M. A. [4 ]
Molberg, O. [3 ]
Franceschini, F. [5 ,6 ]
Cavazzana, I. [5 ,6 ]
Castaneda, S. [7 ]
Lopez Longo, F. J. [8 ]
Balduzzi, S. [1 ,2 ]
Montecucco, C. [1 ,2 ]
Triantafyllias, K. [9 ]
Weinmann-Menke, J. [10 ]
Rojas-Serrano, J. [11 ,12 ]
Sifuentes Giraldo, A. [13 ]
Bachiller-Corral, J. [13 ]
Salaffi, F. [14 ,15 ]
Iannone, F. [16 ]
Giannini, M. [16 ]
Nuno, L. [17 ]
Bonella, F. [18 ]
Costabel, U. [18 ]
Parisi, S. [19 ]
Selmi, C. [20 ]
Scirse, C. [21 ]
Benucci, M. [22 ]
Doria, A. [23 ]
Caporali, R. [1 ,2 ]
Perez-Roman, I. [11 ,12 ]
Ghirardello, A. [23 ]
机构
[1] Univ Pavia, Rheumatol, Pavia, Italy
[2] Irccs Found Policlin S Matteo, Pavia, Italy
[3] Univ Hosp, Rheumatol, Oslo, Norway
[4] Hosp Univ Marques de Valdecilla, Rheumatol, Santander, Spain
[5] Univ Brescia, Rheumatol, Brescia, Italy
[6] AO Spedali Civili, Brescia, Italy
[7] Hosp Univ Princesa, Rheumatol, Madrid, Spain
[8] Hosp Gen Univ G Maranon, Rheumatol, Madrid, Spain
[9] ACURA Ctr, Rheumatol, Bad Kreuznach, Germany
[10] Univ Hosp J Gutenberg, Rheumatol, Mainz, Germany
[11] Inst Nacl Enfermedades Resp, ILD Unit, Tlalpan, Mexico
[12] Inst Nacl Enfermedades Resp, Rheumatol Unit, Tlalpan, Mexico
[13] Univ Hosp Ramon & Cajal, Rheumatol, Madrid, Spain
[14] Univ Marche, Rheumatol, Jesi, Italy
[15] C Urbani Hosp, Jesi, Italy
[16] Univ Bari, Rheumatol, Bari, Italy
[17] Hosp Univ La Paz, Rheumatol, Madrid, Spain
[18] Univ Duisburg Essen, Univ Hosp, Interstitial & Rare Lung Dis Unit, Ruhrlandklin, Essen, Germany
[19] Citta Salute & Sci, Rheumatol, Turin, Italy
[20] Humanitas Res Hosp, Rheumatol, Rozzano, Italy
[21] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy
[22] Nuovo Osp S Giovanni Dio, Rheumatol, Florence, Italy
[23] Univ Padua, Rheumatol, Padua, Italy
关键词
D O I
10.1136/annrheumdis-2016-eular.2205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0291
引用
收藏
页码:540 / 541
页数:2
相关论文
共 50 条
  • [41] Jo-1 syndrome with associated poorly differentiated adenocarcinoma
    Watkins, J
    Farzaneh-Far, R
    Tahir, H
    Wykes, F
    Studdy, PR
    Beynon, HLC
    RHEUMATOLOGY, 2004, 43 (03) : 389 - 390
  • [42] Characterization of interstitial pneumonia in anti Jo-1 antibody positive patients with polymyositis/dermatomyositis.
    Yamasaki, M
    Yamasaki, Y
    Yamada, H
    Niimi, H
    Kurihara, Y
    Hama, N
    Ichikawa, Y
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S193 - S193
  • [43] Hodgkin’s lymphoma in a patient with Jo-1 syndrome
    Alexander C. Adam
    Christian Grohé
    Sebastian Stier
    Stefan Gattenlöhner
    Zeynep Balta
    Reinhard Büttner
    Ines Gütgemann
    Virchows Archiv, 2007, 451 : 101 - 104
  • [44] Arthritis Mutilans in Jo1 Antisynthetase Syndrome
    Bradhurst, Peter
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 961 - 962
  • [45] JO-1 ANTIBODY - A WIDER CLINICAL-SIGNIFICANCE
    MCCARTY, GA
    BAHRT, KM
    SHEPPARD, GL
    CLINICAL RESEARCH, 1985, 33 (02): : A509 - A509
  • [46] Das Jo-1-Syndrom und seine klinischen ManifestationenThe Jo-1 Syndrome—Immunological Findings and Clinical Manifestations
    Bettina Seiberlich
    Nicolas Hunzelmann
    Axel Roers
    Manfred Weber
    Eckhard Schulze-Lohoff
    Medizinische Klinik, 2005, 100 : 137 - 142
  • [47] JO-1 ANTIBODY - A WIDER CLINICAL-SIGNIFICANCE
    MCCARTY, GA
    BAHRT, KM
    SHEPPARD, GL
    CLINICAL RESEARCH, 1985, 33 (03): : A791 - A791
  • [48] Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome
    Legault, Dominic
    McDermott, John
    Crous-Tsanaclis, Ana Maria
    Boire, Gilles
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (01) : 169 - 171
  • [49] Rituxamab treatment reduces Jo-1 antibody titers and improves clinical symptoms in anti-Jo-1-antibody associated myositis
    Mozaffar, Tahseen
    Andrews, Brian S.
    NEUROLOGY, 2007, 68 (12) : A243 - A243
  • [50] Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
    Cavagna, L.
    Meloni, F.
    Meyer, A.
    Sambataro, G.
    Belliato, M.
    De Langhe, E.
    Cavazzana, I
    Pipitone, N.
    Triantafyllias, K.
    Mosca, M.
    Barsotti, S.
    Zampogna, G.
    Biglia, A.
    Emmi, G.
    de Visser, M.
    van der Kooi, A.
    Parronchi, P.
    Hirschi, S.
    da Silva, J. A. P.
    Scire, C. A.
    Furini, F.
    Giannini, M.
    Martinez Gonzalez, O.
    Damian, L.
    Piette, Y.
    Smith, V
    Mera-Varela, A.
    Bachiller-Corral, J.
    Cabezas Rodriguez, I
    Brandy-Garcia, A. M.
    Maurier, F.
    Perrin, J.
    Gonzalez-Moreno, J.
    Drott, U.
    Delbruck, C.
    Schwarting, A.
    Arrigoni, E.
    Sebastiani, G. D.
    Iuliano, A.
    Nannini, C.
    Quartuccio, L.
    Rodriguez Cambron, A. B.
    Blazquez Canamero, M. A.
    Blanco, I. Villa
    Cagnotto, G.
    Pesci, A.
    Luppi, F.
    Dei, G.
    Romero Bueno, F., I
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (02) : 274 - 283